Literature DB >> 30112607

Chitosan-based binary dry powder inhaler carrier with nanometer roughness for improving in vitro and in vivo aerosolization performance.

Ying Huang1, Zhengwei Huang1, Xuejuan Zhang1,2, Ziyu Zhao1, Xuan Zhang1,3, Kexin Wang1, Cheng Ma1, Chune Zhu2, Xin Pan4, Chuanbin Wu1.   

Abstract

Suitable nanometer roughness favors interactions between drugs and carriers, and it is a promising approach to enhance the aerosolization performance of carrier-based dry powder inhalers (DPIs). In this study, by altering the molecular migration rates, chitosan-based binary carriers (CBBCs) with nanometer roughness were fabricated for DPIs. Comprehensive physicochemical characterizations were conducted to elucidate the formation mechanism of the CBBCs. It was hypothesized that different constituent ratios in the formulations would result in different assembling of the particles and diverse roughness scales. The fine particle fractions (FPF, approximately 40~60%) of nanometer roughness CBBC-based DPI formulations were satisfactory, demonstrating the enhancement of the in vitro aerodynamic performance. The positive correlation (R2 = 0.9883) between the nanometer roughness and FPF was revealed, and the surface roughness of 20 nm might achieve the best aerosolization performance. CBBCs (optimal formulations) showed no difference in cytotoxicity on A549 and Calu-3 cells (p > 0.05). Additionally, the increased Cmax and AUC0-8h of the formulation with the nanometer roughness (p < 0.05) were observed in pharmacokinetic studies, which resulted from the improved in vivo aerosolization performance. In summary, the CBBCs were a prospective tool to improve the in vitro and in vivo aerosolization performance of DPIs. Graphical abstract ᅟ.

Entities:  

Keywords:  Carrier; Chitosan; Dry powder inhaler; Fine particle fraction; Nanometer roughness

Mesh:

Substances:

Year:  2018        PMID: 30112607     DOI: 10.1007/s13346-018-0564-y

Source DB:  PubMed          Journal:  Drug Deliv Transl Res        ISSN: 2190-393X            Impact factor:   4.617


  31 in total

1.  Three polymorphs (alpha, beta, and delta) of D-mannitol at 100 K.

Authors:  Frank R Fronczek; Haidy Nasr Kamel; Marc Slattery
Journal:  Acta Crystallogr C       Date:  2003-09-23       Impact factor: 1.172

2.  Spray dried mannitol carrier particles with tailored surface properties--the influence of carrier surface roughness and shape.

Authors:  E M Littringer; A Mescher; H Schroettner; L Achelis; P Walzel; N A Urbanetz
Journal:  Eur J Pharm Biopharm       Date:  2012-05-14       Impact factor: 5.571

3.  Hybrid nanosystems based on natural polymers as protein carriers for respiratory delivery: Stability and toxicological evaluation.

Authors:  Susana Rodrigues; Clara Cordeiro; Begoña Seijo; Carmen Remuñán-López; Ana Grenha
Journal:  Carbohydr Polym       Date:  2015-02-03       Impact factor: 9.381

Review 4.  Pulmonary drug delivery by powder aerosols.

Authors:  Michael Yifei Yang; John Gar Yan Chan; Hak-Kim Chan
Journal:  J Control Release       Date:  2014-05-09       Impact factor: 9.776

5.  Low density, good flowability cyclodextrin-raffinose binary carrier for dry powder inhaler: anti-hygroscopicity and aerosolization performance enhancement.

Authors:  Ziyu Zhao; Zhengwei Huang; Xuejuan Zhang; Ying Huang; Yingtong Cui; Cheng Ma; Guanlin Wang; Tim Freeman; Xiang-Yun Lu; Xin Pan; Chuanbin Wu
Journal:  Expert Opin Drug Deliv       Date:  2018-03-13       Impact factor: 6.648

6.  Nano- and Microstructured model carrier surfaces to alter dry powder inhaler performance.

Authors:  Niklas Renner; Hartwig Steckel; Nora Urbanetz; Regina Scherließ
Journal:  Int J Pharm       Date:  2016-12-23       Impact factor: 5.875

7.  Preparation and Evaluation of Surface Modified Lactose Particles for Improved Performance of Fluticasone Propionate Dry Powder Inhaler.

Authors:  Deepak J Singh; Rajesh R Jain; P S Soni; Samad Abdul; Hegde Darshana; Rajiv V Gaikwad; Mala D Menon
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2014-12-17       Impact factor: 2.849

8.  Drug permeation and cellular interaction of amino acid-coated drug combination powders for pulmonary delivery.

Authors:  Ville Vartiainen; Luis M Bimbo; Jouni Hirvonen; Esko I Kauppinen; Janne Raula
Journal:  Int J Pharm       Date:  2016-03-29       Impact factor: 5.875

9.  Pulmonary targeting potential of rosuvastatin loaded nanostructured lipid carrier: Optimization by factorial design.

Authors:  Arpana Patil-Gadhe; Varsha Pokharkar
Journal:  Int J Pharm       Date:  2016-02-01       Impact factor: 5.875

Review 10.  Inhalable nanoparticulate powders for respiratory delivery.

Authors:  Priya Muralidharan; Monica Malapit; Evan Mallory; Don Hayes; Heidi M Mansour
Journal:  Nanomedicine       Date:  2015-02-04       Impact factor: 5.307

View more
  3 in total

1.  Preparation of an oil suspension containing ondansetron hydrochloride as a sustained release parenteral formulation.

Authors:  Thi-Thao-Linh Nguyen; Van-An Duong; Han-Joo Maeng; Sang-Cheol Chi
Journal:  Drug Deliv Transl Res       Date:  2020-02       Impact factor: 4.617

2.  Development of Inhalable Nanostructured Lipid Carriers for Ciprofloxacin for Noncystic Fibrosis Bronchiectasis Treatment.

Authors:  Alanood S Almurshedi; Basmah N Aldosari; Hessah A Aljunaidel; Bushra Alquadeib; Iman M Alfagih; Salma S Almarshidy; Eram K D Eltahir; Amany Z Mohamoud
Journal:  Int J Nanomedicine       Date:  2021-03-25

3.  A real-time and modular approach for quick detection and mechanism exploration of DPIs with different carrier particle sizes.

Authors:  Yingtong Cui; Ying Huang; Xuejuan Zhang; Xiangyun Lu; Jun Xue; Guanlin Wang; Ping Hu; Xiao Yue; Ziyu Zhao; Xin Pan; Chuanbin Wu
Journal:  Acta Pharm Sin B       Date:  2021-06-21       Impact factor: 11.413

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.